Publications by authors named "Marion Divoux"

Claim this Profile
A
A molecular signature predicts hematologic evolution in polycythemia vera patients.
Olivier Mansier, Eric Lippert, Lina Benajiba, Dana Ranta, François Girodon, Marion Divoux

Leukemia· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic and immunogenomic profiling of extramedullary acute myeloid leukemia reveals actionable clonal branching and frequent immune editing.
Clément Collignon, Tucker Hansen, Colin Hercus, Marianna B Ruzinova, Gabrielle Roth Guepin, Marion Divoux

Blood Cancer J· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antihuman T Lymphocyte Globulin Fresenius in Graft-Versus-Host Disease Prophylaxis for Unrelated Hematopoietic Stem Cell Transplantation After Myeloablative Conditioning: A Long-Term Real-Life Retrospective Study.
Marion Divoux, Matthieu Resche-Rigon, David Michonneau, Aurélien Sutra Del Galy, Nathalie Dhedin

Am J Hematol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expanding the genetic and clinical spectrum of Tatton-Brown-Rahman syndrome in a series of 24 French patients.
Hortense Thomas, Tom Alix, Émeline Renard, Mathilde Renaud, Justine Wourms, Marion Divoux

J Med Genet· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CALR-mutated patients with low allele burden represent a specific subtype of essential thrombocythemia: A study on behalf of FIM and GBMHM.
Laura Aubin, Rúben Vilas Boas, Rafael Daltro De Oliveira, Valoris Le Brun, Marion Divoux

Am J Hematol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterogeneity in long-term outcomes for patients with Revised International Staging System stage II, newly diagnosed multiple myeloma.
Anais Schavgoulidze, Valerie Lauwers-Cances, Aurore Perrot, Titouan Cazaubiel, Marie-Lorraine Chretien, Marion Divoux

Haematologica· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Multiple Myeloma, High-Risk Secondary Genetic Events Observed at Relapse Are Present From Diagnosis in Tiny, Undetectable Subclonal Populations.
Romain Lannes, Mehmet Samur, Aurore Perrot, Celine Mazzotti, Marion Divoux

J Clin Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biallelic deletion of 1p32 defines ultra-high-risk myeloma, but monoallelic del(1p32) remains a strong prognostic factor.
Anaïs Schavgoulidze, Alexis Talbot, Aurore Perrot, Titouan Cazaubiel, Xavier Leleu, Marion Divoux

Blood· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation between DNA Methylation and Cell Proliferation Identifies New Candidate Predictive Markers in Meningioma.
Sébastien Hergalant, Chloé Saurel, Marion Divoux, Fabien Rech, Celso Pouget

Cancers (Basel)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary plasma cell leukemias displaying t(11;14) have specific genomic, transcriptional, and clinical features.
Titouan Cazaubiel, Xavier Leleu, Aurore Perrot, Salomon Manier, Laure Buisson, Marion Divoux

Blood· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of lenalidomide in myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and an extreme platelet count.
Marion Divoux, Alexia Plocque, Margaux Sevin, Laurent Voillat, Pierre Feugier

Clin Case Rep· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis